Avidity Biosciences, Inc.
RNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $220 | $185 | $340 | $320 |
| Short-Term Investments | $1,282 | $410 | $270 | $85 |
| Receivables | $28 | $9 | $4 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $7 | $8 | $5 |
| Total Curr. Assets | $1,542 | $611 | $623 | $411 |
| Property Plant & Equip (Net) | $18 | $17 | $15 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $1 | $1 | $1 |
| Total NC Assets | $22 | $17 | $16 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,564 | $629 | $639 | $428 |
| Liabilities | – | – | – | – |
| Payables | $8 | $9 | $5 | $3 |
| Short-Term Debt | $4 | $4 | $3 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $21 | $28 | $5 | $0 |
| Other Curr. Liab. | $65 | $40 | $39 | $25 |
| Total Curr. Liab. | $98 | $81 | $52 | $30 |
| LT Debt | $3 | $6 | $8 | $10 |
| Deferred Rev, NC | $38 | $41 | $1 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $7 |
| Total NC Liab. | $41 | $47 | $9 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $10 | $11 | $12 |
| Total Liabilities | $139 | $128 | $61 | $46 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$893 | -$571 | -$359 | -$185 |
| AOCI | $3 | $0 | -$3 | -$0 |
| Other Equity | $2,315 | $1,071 | $939 | $566 |
| Total Equity | $1,425 | $501 | $578 | $381 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,564 | $629 | $639 | $428 |
| Net Debt | -$213 | -$175 | -$330 | -$309 |